BPC
NVO

Banque Pictet & Cie’s Novo Nordisk NVO Stock Holding History

Banque Pictet & Cie’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06M Sell
84,670
-2,100
-2% -$90.2K 0.03% 157
2026
Q1 		$3.19M Buy
86,770
+122
+0.1% +$5.78K 0.02% 182
2025
Q4 		$4.41M Buy
86,648
+35,142
+68% +$1.8M 0.03% 160
2025
Q3 		$2.86M Sell
51,506
-289
-0.6% -$16.9K 0.02% 195
2025
Q2 		$3.57M Buy
51,795
+15,170
+41% +$1.03M 0.02% 177
2025
Q1 		$2.54M Buy
36,625
+446
+1% +$36.8K 0.02% 197
2024
Q4 		$3.11M Buy
36,179
+14,437
+66% +$1.56M 0.02% 195
2024
Q3 		$2.59M Buy
21,742
+14,565
+203% +$1.94M 0.02% 179
2024
Q2 		$1.02M Buy
+7,177
New +$951K 0.01% 228
2023
Q4 		– Sell
-2,532
Closed -$230K – 434
2023
Q3 		$230K Hold
2,532
– – ﹤0.01% 413
2023
Q2 		$205K Hold
2,532
– – ﹤0.01% 468
2023
Q1 		$201K Sell
2,532
-2,900
-53% -$206K ﹤0.01% 556
2022
Q4 		$368K Buy
+5,432
New +$318K ﹤0.01% 544
2017
Q2 		– Sell
-26,228
Closed -$452K – 376
2017
Q1 		$452K Buy
+26,228
New +$457K 0.01% 283

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Banque Pictet & Cie's NVO Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Novo Nordisk (NVO) stake by 2.4% in Q2 2026, selling an estimated $90.2K and leaving 84,670 shares worth $4.06M. The position accounts for 0.03% of the portfolio, ranked #157.

Banque Pictet & Cie first reported a position in NVO in Q1 2017 and has held it in 14 quarters since. The position peaked at $4.41M in Q4 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Banque Pictet & Cie held 84,670 shares of Novo Nordisk worth $4.06M as of Q2 2026.
  • Banque Pictet & Cie sold 2,100 Novo Nordisk shares in Q2 2026, an estimated $90.2K.
  • Novo Nordisk made up 0.03% of Banque Pictet & Cie's portfolio in Q2 2026, its #157 holding.
  • Banque Pictet & Cie first reported a position in Novo Nordisk in Q1 2017 and has held it in 14 quarters since.
  • Banque Pictet & Cie's Novo Nordisk position peaked at $4.41M in Q4 2025.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.